Wanjun Chen

Company: National Institute of Health

Job title: Senior Investigator, Chief, Mucosal Immunology Section

Seminars:

Matching the Modality to the Disease: What Cell Therapy Type is Best for Which Indication? 9:00 am

As B cells are crucial to the pathogenesis of many autoimmune diseases, CD19 makes an attractive target because its expression is limited to those of a B-cell lineage. Additionally, the field has commonly developed therapies to treat indications such as lupus, multiple sclerosis, rheumatoid arthritis, and type 1 diabetes. But, what’s next for the field?…Read more

day: Pre-Conference Day